Merck & Co (MRK)
$80.36 0.30 (0.37%)
9:18 EST MRK Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 216.19B
PE Ratio 138.55
Volume (Avg. Vol.) 9,107
Day's Range 80.06 - 80.06
52-Week Range 65.25 - 92.64
Dividend & Yield 1.92 (2.39%)
MRK Stock Predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
MRK stock has entered a new swashbuckling era, searching for new profit gushers like Keytruda, the company's anti-cancer drug.
By Thomas Niel
If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times: Coal, Cruise Lines, Oil and Gas, Pharmaceuticals, Ride Sharing. Tread carefully as voters head to the polls.
By Joel Baglole
Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.
It’s an exciting time for mergers and acquisitions in some of the hottest sectors -- including software, cloud services, artificial intelligence and health care. Here are four major mergers to watch.
Some traders consider Merck stock to be a safe Dow Jones type of investment. Yet, the Covid-19 vaccine angle could propel the share price.
Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
Biotech stocks are on fire at the moment. That said, here are five names from the sector that offer long-term value and strong fundamentals.
MRK stock isn't bad. It has a reasonable valuation, okay growth and a solid dividend. But Merck isn't my favorite pick in biotech.
Merck (MRK) earnings for the pharmaceutical company's second quarter of 2020 have MRK stock up on Friday after beating estimates.
Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.
Merck stock has outperformed large-cap pharma stocks. But that's a low bar to clear, leaving investors with more attractive options elsewhere.
Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.
In another instance of the market fighting off weak economic data, stocks rallied Thursday despite another spike in weekly jobless numbers.
From The Motley Fool
From Market News Video
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Merck & Co Inc (MRK), where a total of 39,933 contracts have traded so far, representing approximately 4.0 million underlying shares. That amounts to about 45.9% of MRK's average daily trading volume over the past month of 8.7 million shares..
From Talk Markets
Navellier RatingsPowered by Portfolio Grader